NDC11 71573010201
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 71573-0102-01 | 71573-0102 |
| 71573-0102-1 | 71573-0102 |
| 71573-102-01 | 71573-102 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Prosoria Psoriasis Treatment | SALICYLIC ACID | Nuvothera, Inc. | 378311aa-95f7-4c69-bc00-e688468262bd | 2026-08-18 | Warnings | 71573-102-01 71573010201 |
| Prosoria Psoriasis Treatment | SALICYLIC ACID | Nuvothera, Inc. | f94f4481-c58e-4555-9863-cbaa2c4cdd07 | 2024-01-10 | Warnings | 71573-102-01 71573-102 71573010201 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.